Efficacy of Hydroxyurea in Patients With Sickle Cell Anemia in a Low-Income Country (Côte d’Ivoire)
Conclusion: Hydroxyurea has an important clinical benefit by reducing the incidence of vaso-occlusive events, infections, and transfusions, which translates into fewer hospitalizations. The main problem is that it is not accessible to most of our patients who live in poor socioeconomic conditions.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Anemia |
| Online Access: | http://dx.doi.org/10.1155/anem/3576890 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|